ARCHIVES

Velcade Plus Dexamethasone Provides 20% Response In First-Line Treatment

This article is from The Cancer Letter archive.

Vol. 29 No. 12 | December 29, 2006

Download PDF Visit The Full Archive

Related Articles

NIH Consensus Conference Concludes That MRI In “Unusually Rewarding,” Calls For More Studies

November 6, 1987

“Of Sofas and Chairs” at MD Anderson: Official Seeks Protection from “Losers,” Explains Costly Interior Design Choices

June 7, 2013

FDA Tightens Conflict of Interest Rules For Advisors.

March 23, 2007

National Lung Cancer Partnership Announces Annual Grant Competition

August 9, 2013

NCI Could Fund 840 Competing Grants Under Clinton Budget

April 16, 1993

Radio-Immunotherapy Advances May Rival Those With Drugs

April 16, 1976